21 CFR 520.608

§ 520.608 Dicloxacillin.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.608, § 520.608 Dicloxacillin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87130
Permanent ID: ys:prov:87130@1
SHA-256: f1363d3ddb3f884d666866150b53c376e94322ff6d11006d0ff0ea0487a474ac

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each capsule contains dicloxacillin sodium monohydrate equivalent to 50, 100, 200, or 500 milligrams of dicloxacillin. (b) Sponsor. See No. 054771 in § 510.600 (c) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer orally 5 to 10 milligrams per pound of body weight, three times daily. In severe cases, up to 25 milligrams per pound of body weight three times daily. (2) Indications for use. For the treatment of pyoderma (pyogenic dermatitis) due to penicillinase-producing staphylococci sensitive to dicloxacillin. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.